{"title":"口腔健康与神经退行性变之间的联系:阿尔茨海默病、帕金森病和痴呆症牙周炎的综述。","authors":"Pooja Wagaskar, Sayali Gaikwad, Meghraj Suryawanshi, Ashwani Patil","doi":"10.1007/s10787-025-01888-7","DOIUrl":null,"url":null,"abstract":"<p><p>This review aims to explore the relationship between periodontitis and neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and dementia. It also aims to evaluate the existing evidence and discuss whether periodontitis could be considered a modifiable risk factor in the prevention or progression of neurodegenerative conditions. Neurodegenerative diseases like Alzheimer's, Parkinson's, and dementia are among the most challenging health issues of our time, especially with aging populations worldwide. Interestingly, recent research suggests that the health of our mouth-particularly chronic gum disease known as periodontitis-might be more closely linked to brain health than we ever realized. This review explores the growing body of evidence connecting periodontitis with neurodegeneration. We examine how oral bacteria and the inflammation they cause can enter the bloodstream, reach the brain, and potentially trigger or worsen conditions like Alzheimer's and Parkinson's disease. From preclinical models to clinical trials, the data show intriguing overlaps in the biological pathways involved, particularly inflammation, immune responses, and abnormal protein accumulation. While more research is still needed to confirm direct cause-and-effect relationships, the existing findings raise an important question: could improving oral health be a simple, preventive step toward protecting the brain? This review aims to shed light on that possibility and encourages further exploration into treating periodontitis not just as a dental issue, but as a potential key to slowing down or preventing neurodegenerative diseases.</p>","PeriodicalId":13551,"journal":{"name":"Inflammopharmacology","volume":" ","pages":"5023-5036"},"PeriodicalIF":5.3000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The link between oral health and neurodegeneration: a review of periodontitis in Alzheimer's and Parkinson's disease and dementia.\",\"authors\":\"Pooja Wagaskar, Sayali Gaikwad, Meghraj Suryawanshi, Ashwani Patil\",\"doi\":\"10.1007/s10787-025-01888-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This review aims to explore the relationship between periodontitis and neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and dementia. It also aims to evaluate the existing evidence and discuss whether periodontitis could be considered a modifiable risk factor in the prevention or progression of neurodegenerative conditions. Neurodegenerative diseases like Alzheimer's, Parkinson's, and dementia are among the most challenging health issues of our time, especially with aging populations worldwide. Interestingly, recent research suggests that the health of our mouth-particularly chronic gum disease known as periodontitis-might be more closely linked to brain health than we ever realized. This review explores the growing body of evidence connecting periodontitis with neurodegeneration. We examine how oral bacteria and the inflammation they cause can enter the bloodstream, reach the brain, and potentially trigger or worsen conditions like Alzheimer's and Parkinson's disease. From preclinical models to clinical trials, the data show intriguing overlaps in the biological pathways involved, particularly inflammation, immune responses, and abnormal protein accumulation. While more research is still needed to confirm direct cause-and-effect relationships, the existing findings raise an important question: could improving oral health be a simple, preventive step toward protecting the brain? This review aims to shed light on that possibility and encourages further exploration into treating periodontitis not just as a dental issue, but as a potential key to slowing down or preventing neurodegenerative diseases.</p>\",\"PeriodicalId\":13551,\"journal\":{\"name\":\"Inflammopharmacology\",\"volume\":\" \",\"pages\":\"5023-5036\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Inflammopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10787-025-01888-7\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10787-025-01888-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
The link between oral health and neurodegeneration: a review of periodontitis in Alzheimer's and Parkinson's disease and dementia.
This review aims to explore the relationship between periodontitis and neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and dementia. It also aims to evaluate the existing evidence and discuss whether periodontitis could be considered a modifiable risk factor in the prevention or progression of neurodegenerative conditions. Neurodegenerative diseases like Alzheimer's, Parkinson's, and dementia are among the most challenging health issues of our time, especially with aging populations worldwide. Interestingly, recent research suggests that the health of our mouth-particularly chronic gum disease known as periodontitis-might be more closely linked to brain health than we ever realized. This review explores the growing body of evidence connecting periodontitis with neurodegeneration. We examine how oral bacteria and the inflammation they cause can enter the bloodstream, reach the brain, and potentially trigger or worsen conditions like Alzheimer's and Parkinson's disease. From preclinical models to clinical trials, the data show intriguing overlaps in the biological pathways involved, particularly inflammation, immune responses, and abnormal protein accumulation. While more research is still needed to confirm direct cause-and-effect relationships, the existing findings raise an important question: could improving oral health be a simple, preventive step toward protecting the brain? This review aims to shed light on that possibility and encourages further exploration into treating periodontitis not just as a dental issue, but as a potential key to slowing down or preventing neurodegenerative diseases.
期刊介绍:
Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn''s disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:
-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states
-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs
-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents
-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain
-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs
-Muscle-immune interactions during inflammation [...]